HEADER PROTEIN BINDING 03-JUN-22 8A2H TITLE HUMAN STING IN COMPLEX WITH 2',3'-CYCLIC-GMP-7-DEAZAPHENYL-AMP COMPND MOL_ID: 1; COMPND 2 MOLECULE: STIMULATOR OF INTERFERON GENES PROTEIN; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: HSTING,ENDOPLASMIC RETICULUM INTERFERON STIMULATOR,ERIS, COMPND 5 MEDIATOR OF IRF3 ACTIVATION,HMITA,TRANSMEMBRANE PROTEIN 173; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: STING1, ERIS, MITA, STING, TMEM173; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS COMPLEX, STING, CYCLIC DINUCLEOTIDE, PROTEIN BINDING EXPDTA X-RAY DIFFRACTION AUTHOR M.SMOLA,Z.VAVRINA,E.BOURA,J.BRYNDA REVDAT 5 07-FEB-24 8A2H 1 REMARK REVDAT 4 24-MAY-23 8A2H 1 FORMUL REVDAT 3 09-NOV-22 8A2H 1 JRNL REVDAT 2 19-OCT-22 8A2H 1 JRNL REVDAT 1 12-OCT-22 8A2H 0 JRNL AUTH Z.VAVRINA,P.PERLIKOVA,N.MILISAVLJEVIC,F.CHEVRIER,M.SMOLA, JRNL AUTH 2 J.SMITH,M.DEJMEK,V.HAVLICEK,M.BUDESINSKY,R.LIBOSKA, JRNL AUTH 3 L.VANEKOVA,J.BRYNDA,E.BOURA,P.REZACOVA,M.HOCEK,G.BIRKUS JRNL TITL DESIGN, SYNTHESIS, AND BIOCHEMICAL AND BIOLOGICAL EVALUATION JRNL TITL 2 OF NOVEL 7-DEAZAPURINE CYCLIC DINUCLEOTIDE ANALOGUES AS JRNL TITL 3 STING RECEPTOR AGONISTS. JRNL REF J.MED.CHEM. V. 65 14082 2022 JRNL REFN ISSN 0022-2623 JRNL PMID 36201304 JRNL DOI 10.1021/ACS.JMEDCHEM.2C01305 REMARK 2 REMARK 2 RESOLUTION. 2.69 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.8.0352 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.69 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 44.14 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.2 REMARK 3 NUMBER OF REFLECTIONS : 11333 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.247 REMARK 3 R VALUE (WORKING SET) : 0.245 REMARK 3 FREE R VALUE : 0.285 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 597 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.69 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.76 REMARK 3 REFLECTION IN BIN (WORKING SET) : 777 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 94.02 REMARK 3 BIN R VALUE (WORKING SET) : 0.2710 REMARK 3 BIN FREE R VALUE SET COUNT : 41 REMARK 3 BIN FREE R VALUE : 0.3270 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2792 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 51 REMARK 3 SOLVENT ATOMS : 102 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 47.16 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 35.34 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -0.75000 REMARK 3 B22 (A**2) : 0.89000 REMARK 3 B33 (A**2) : -0.14000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.344 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.399 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.000 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 0.009 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.928 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.882 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): NULL ; NULL ; NULL REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): NULL ; NULL ; NULL REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): NULL ; NULL ; NULL REMARK 3 GENERAL PLANES REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : BABINET MODEL WITH MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 8A2H COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 07-JUN-22. REMARK 100 THE DEPOSITION ID IS D_1292123422. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 02-DEC-19 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU MICROMAX-007 HF REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.541870 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 200K REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XSCALE REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 21745 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.690 REMARK 200 RESOLUTION RANGE LOW (A) : 44.140 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.5 REMARK 200 DATA REDUNDANCY : 3.333 REMARK 200 R MERGE (I) : 0.17800 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 6.1900 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.69 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.85 REMARK 200 COMPLETENESS FOR SHELL (%) : 96.5 REMARK 200 DATA REDUNDANCY IN SHELL : 3.38 REMARK 200 R MERGE FOR SHELL (I) : 0.97400 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 1.240 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER 2.8.3 REMARK 200 STARTING MODEL: 4KSY REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): NULL REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): NULL REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 200MM AMMONIUM NITRATE, 20% (W/V) PEG REMARK 280 3350, 10MM EDTA, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 291K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z REMARK 290 3555 -X+1/2,Y+1/2,-Z REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 47.59350 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 58.99000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 47.59350 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 58.99000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 SER A 139 REMARK 465 ALA A 140 REMARK 465 PRO A 141 REMARK 465 ALA A 142 REMARK 465 GLU A 143 REMARK 465 ILE A 144 REMARK 465 SER A 145 REMARK 465 ALA A 146 REMARK 465 VAL A 147 REMARK 465 CYS A 148 REMARK 465 GLU A 149 REMARK 465 LYS A 150 REMARK 465 PRO A 317 REMARK 465 ALA A 318 REMARK 465 ASP A 319 REMARK 465 ASP A 320 REMARK 465 GLU A 337 REMARK 465 LYS A 338 REMARK 465 GLU A 339 REMARK 465 GLU A 340 REMARK 465 VAL A 341 REMARK 465 THR A 342 REMARK 465 VAL A 343 REMARK 465 GLY A 344 REMARK 465 SER A 345 REMARK 465 LEU A 346 REMARK 465 LYS A 347 REMARK 465 THR A 348 REMARK 465 SER A 349 REMARK 465 ALA A 350 REMARK 465 VAL A 351 REMARK 465 PRO A 352 REMARK 465 SER A 353 REMARK 465 THR A 354 REMARK 465 SER A 355 REMARK 465 THR A 356 REMARK 465 MET A 357 REMARK 465 SER A 358 REMARK 465 GLN A 359 REMARK 465 GLU A 360 REMARK 465 PRO A 361 REMARK 465 GLU A 362 REMARK 465 LEU A 363 REMARK 465 LEU A 364 REMARK 465 ILE A 365 REMARK 465 SER A 366 REMARK 465 GLY A 367 REMARK 465 MET A 368 REMARK 465 GLU A 369 REMARK 465 LYS A 370 REMARK 465 PRO A 371 REMARK 465 LEU A 372 REMARK 465 PRO A 373 REMARK 465 LEU A 374 REMARK 465 ARG A 375 REMARK 465 THR A 376 REMARK 465 ASP A 377 REMARK 465 PHE A 378 REMARK 465 SER A 379 REMARK 465 SER B 139 REMARK 465 ALA B 140 REMARK 465 PRO B 141 REMARK 465 ALA B 142 REMARK 465 GLU B 143 REMARK 465 ILE B 144 REMARK 465 SER B 145 REMARK 465 ALA B 146 REMARK 465 VAL B 147 REMARK 465 CYS B 148 REMARK 465 GLU B 149 REMARK 465 LYS B 150 REMARK 465 GLY B 151 REMARK 465 ASN B 152 REMARK 465 PHE B 153 REMARK 465 TYR B 186 REMARK 465 ASN B 187 REMARK 465 ASN B 188 REMARK 465 LEU B 189 REMARK 465 LEU B 190 REMARK 465 ARG B 191 REMARK 465 GLY B 192 REMARK 465 ALA B 318 REMARK 465 GLU B 340 REMARK 465 VAL B 341 REMARK 465 THR B 342 REMARK 465 VAL B 343 REMARK 465 GLY B 344 REMARK 465 SER B 345 REMARK 465 LEU B 346 REMARK 465 LYS B 347 REMARK 465 THR B 348 REMARK 465 SER B 349 REMARK 465 ALA B 350 REMARK 465 VAL B 351 REMARK 465 PRO B 352 REMARK 465 SER B 353 REMARK 465 THR B 354 REMARK 465 SER B 355 REMARK 465 THR B 356 REMARK 465 MET B 357 REMARK 465 SER B 358 REMARK 465 GLN B 359 REMARK 465 GLU B 360 REMARK 465 PRO B 361 REMARK 465 GLU B 362 REMARK 465 LEU B 363 REMARK 465 LEU B 364 REMARK 465 ILE B 365 REMARK 465 SER B 366 REMARK 465 GLY B 367 REMARK 465 MET B 368 REMARK 465 GLU B 369 REMARK 465 LYS B 370 REMARK 465 PRO B 371 REMARK 465 LEU B 372 REMARK 465 PRO B 373 REMARK 465 LEU B 374 REMARK 465 ARG B 375 REMARK 465 THR B 376 REMARK 465 ASP B 377 REMARK 465 PHE B 378 REMARK 465 SER B 379 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ARG A 180 CG CD NE CZ NH1 NH2 REMARK 470 ARG A 191 CG CD NE CZ NH1 NH2 REMARK 470 MET A 214 CG SD CE REMARK 470 ARG A 220 CG CD NE CZ NH1 NH2 REMARK 470 LYS A 236 CG CD CE NZ REMARK 470 GLN A 252 CG CD OE1 NE2 REMARK 470 ARG A 281 CG CD NE CZ NH1 NH2 REMARK 470 LEU A 285 CG CD1 CD2 REMARK 470 ARG A 310 CG CD NE CZ NH1 NH2 REMARK 470 GLU A 316 CG CD OE1 OE2 REMARK 470 SER A 321 OG REMARK 470 SER A 322 OG REMARK 470 ARG B 180 CG CD NE CZ NH1 NH2 REMARK 470 GLN B 184 CG CD OE1 NE2 REMARK 470 HIS B 185 CG ND1 CD2 CE1 NE2 REMARK 470 VAL B 194 CG1 CG2 REMARK 470 ARG B 197 CG CD NE CZ NH1 NH2 REMARK 470 ARG B 220 CG CD NE CZ NH1 NH2 REMARK 470 LYS B 236 CG CD CE NZ REMARK 470 ARG B 238 CG CD NE CZ NH1 NH2 REMARK 470 VAL B 239 CG1 CG2 REMARK 470 ARG B 281 CG CD NE CZ NH1 NH2 REMARK 470 ASP B 319 CG OD1 OD2 REMARK 470 ASP B 320 CG OD1 OD2 REMARK 470 SER B 321 OG REMARK 470 LYS B 338 CG CD CE NZ REMARK 470 GLU B 339 CG CD OE1 OE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15 REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375 REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS. REMARK 500 REMARK 500 DISTANCE CUTOFF: REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE REMARK 500 O HOH B 426 O HOH B 426 2555 2.19 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 TYR A 167 -65.41 -136.09 REMARK 500 ASP A 237 62.62 63.65 REMARK 500 TYR B 167 -62.31 -137.52 REMARK 500 ASP B 216 118.33 -165.63 REMARK 500 LEU B 222 -58.04 -122.15 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 8A2I RELATED DB: PDB REMARK 900 RELATED ID: 8A2J RELATED DB: PDB REMARK 900 RELATED ID: 8A2K RELATED DB: PDB DBREF 8A2H A 140 379 UNP Q86WV6 STING_HUMAN 140 379 DBREF 8A2H B 140 379 UNP Q86WV6 STING_HUMAN 140 379 SEQADV 8A2H SER A 139 UNP Q86WV6 EXPRESSION TAG SEQADV 8A2H ARG A 232 UNP Q86WV6 HIS 232 VARIANT SEQADV 8A2H SER B 139 UNP Q86WV6 EXPRESSION TAG SEQADV 8A2H ARG B 232 UNP Q86WV6 HIS 232 VARIANT SEQRES 1 A 241 SER ALA PRO ALA GLU ILE SER ALA VAL CYS GLU LYS GLY SEQRES 2 A 241 ASN PHE ASN VAL ALA HIS GLY LEU ALA TRP SER TYR TYR SEQRES 3 A 241 ILE GLY TYR LEU ARG LEU ILE LEU PRO GLU LEU GLN ALA SEQRES 4 A 241 ARG ILE ARG THR TYR ASN GLN HIS TYR ASN ASN LEU LEU SEQRES 5 A 241 ARG GLY ALA VAL SER GLN ARG LEU TYR ILE LEU LEU PRO SEQRES 6 A 241 LEU ASP CYS GLY VAL PRO ASP ASN LEU SER MET ALA ASP SEQRES 7 A 241 PRO ASN ILE ARG PHE LEU ASP LYS LEU PRO GLN GLN THR SEQRES 8 A 241 GLY ASP ARG ALA GLY ILE LYS ASP ARG VAL TYR SER ASN SEQRES 9 A 241 SER ILE TYR GLU LEU LEU GLU ASN GLY GLN ARG ALA GLY SEQRES 10 A 241 THR CYS VAL LEU GLU TYR ALA THR PRO LEU GLN THR LEU SEQRES 11 A 241 PHE ALA MET SER GLN TYR SER GLN ALA GLY PHE SER ARG SEQRES 12 A 241 GLU ASP ARG LEU GLU GLN ALA LYS LEU PHE CYS ARG THR SEQRES 13 A 241 LEU GLU ASP ILE LEU ALA ASP ALA PRO GLU SER GLN ASN SEQRES 14 A 241 ASN CYS ARG LEU ILE ALA TYR GLN GLU PRO ALA ASP ASP SEQRES 15 A 241 SER SER PHE SER LEU SER GLN GLU VAL LEU ARG HIS LEU SEQRES 16 A 241 ARG GLN GLU GLU LYS GLU GLU VAL THR VAL GLY SER LEU SEQRES 17 A 241 LYS THR SER ALA VAL PRO SER THR SER THR MET SER GLN SEQRES 18 A 241 GLU PRO GLU LEU LEU ILE SER GLY MET GLU LYS PRO LEU SEQRES 19 A 241 PRO LEU ARG THR ASP PHE SER SEQRES 1 B 241 SER ALA PRO ALA GLU ILE SER ALA VAL CYS GLU LYS GLY SEQRES 2 B 241 ASN PHE ASN VAL ALA HIS GLY LEU ALA TRP SER TYR TYR SEQRES 3 B 241 ILE GLY TYR LEU ARG LEU ILE LEU PRO GLU LEU GLN ALA SEQRES 4 B 241 ARG ILE ARG THR TYR ASN GLN HIS TYR ASN ASN LEU LEU SEQRES 5 B 241 ARG GLY ALA VAL SER GLN ARG LEU TYR ILE LEU LEU PRO SEQRES 6 B 241 LEU ASP CYS GLY VAL PRO ASP ASN LEU SER MET ALA ASP SEQRES 7 B 241 PRO ASN ILE ARG PHE LEU ASP LYS LEU PRO GLN GLN THR SEQRES 8 B 241 GLY ASP ARG ALA GLY ILE LYS ASP ARG VAL TYR SER ASN SEQRES 9 B 241 SER ILE TYR GLU LEU LEU GLU ASN GLY GLN ARG ALA GLY SEQRES 10 B 241 THR CYS VAL LEU GLU TYR ALA THR PRO LEU GLN THR LEU SEQRES 11 B 241 PHE ALA MET SER GLN TYR SER GLN ALA GLY PHE SER ARG SEQRES 12 B 241 GLU ASP ARG LEU GLU GLN ALA LYS LEU PHE CYS ARG THR SEQRES 13 B 241 LEU GLU ASP ILE LEU ALA ASP ALA PRO GLU SER GLN ASN SEQRES 14 B 241 ASN CYS ARG LEU ILE ALA TYR GLN GLU PRO ALA ASP ASP SEQRES 15 B 241 SER SER PHE SER LEU SER GLN GLU VAL LEU ARG HIS LEU SEQRES 16 B 241 ARG GLN GLU GLU LYS GLU GLU VAL THR VAL GLY SER LEU SEQRES 17 B 241 LYS THR SER ALA VAL PRO SER THR SER THR MET SER GLN SEQRES 18 B 241 GLU PRO GLU LEU LEU ILE SER GLY MET GLU LYS PRO LEU SEQRES 19 B 241 PRO LEU ARG THR ASP PHE SER HET OK6 A 401 51 HETNAM OK6 2-AZANYL-9-[(1~{R},6~{R},8~{R},9~{R},10~{S},15~{R}, HETNAM 2 OK6 17~{R},18~{R})-8-(4-AZANYL-5-PHENYL-PYRROLO[2,3- HETNAM 3 OK6 D]PYRIMIDIN-7-YL)-3,9,12,18-TETRAKIS(OXIDANYL)-3,12- HETNAM 4 OK6 BIS(OXIDANYLIDENE)-2,4,7,11,13,16-HEXAOXA-3$L^{5}, HETNAM 5 OK6 12$L^{5}-DIPHOSPHATRICYCLO[13.2.1.0^{6,10}]OCTADECAN- HETNAM 6 OK6 17-YL]-1~{H}-PURIN-6-ONE HETSYN OK6 2',3'-CYCLIC-GMP-7-DEAZAPHENYL-AMP FORMUL 3 OK6 C27 H29 N9 O13 P2 FORMUL 4 HOH *102(H2 O) HELIX 1 AA1 GLY A 151 GLY A 166 1 16 HELIX 2 AA2 TYR A 167 ASN A 187 1 21 HELIX 3 AA3 ASN A 211 ASP A 216 1 6 HELIX 4 AA4 PRO A 264 SER A 272 1 9 HELIX 5 AA5 SER A 280 ASP A 301 1 22 HELIX 6 AA6 SER A 324 GLU A 336 1 13 HELIX 7 AA7 VAL B 155 TYR B 167 1 13 HELIX 8 AA8 TYR B 167 LEU B 172 1 6 HELIX 9 AA9 GLU B 174 HIS B 185 1 12 HELIX 10 AB1 ASN B 211 ALA B 215 5 5 HELIX 11 AB2 THR B 263 TYR B 274 1 12 HELIX 12 AB3 SER B 275 GLY B 278 5 4 HELIX 13 AB4 SER B 280 ASP B 301 1 22 HELIX 14 AB5 ALA B 302 ASN B 307 1 6 HELIX 15 AB6 SER B 324 GLU B 337 1 14 SHEET 1 AA1 5 ILE A 219 LYS A 224 0 SHEET 2 AA1 5 SER A 243 GLU A 249 -1 O ILE A 244 N ASP A 223 SHEET 3 AA1 5 GLN A 252 TYR A 261 -1 O GLN A 252 N GLU A 249 SHEET 4 AA1 5 LEU A 198 PRO A 203 1 N TYR A 199 O VAL A 258 SHEET 5 AA1 5 CYS A 309 TYR A 314 1 O ILE A 312 N LEU A 202 SHEET 1 AA2 2 GLN A 228 ARG A 232 0 SHEET 2 AA2 2 ILE A 235 TYR A 240 -1 O TYR A 240 N GLN A 228 SHEET 1 AA3 5 ILE B 219 LYS B 224 0 SHEET 2 AA3 5 SER B 243 GLU B 249 -1 O ILE B 244 N ASP B 223 SHEET 3 AA3 5 GLN B 252 TYR B 261 -1 O CYS B 257 N TYR B 245 SHEET 4 AA3 5 LEU B 198 PRO B 203 1 N LEU B 201 O GLU B 260 SHEET 5 AA3 5 CYS B 309 TYR B 314 1 O ILE B 312 N LEU B 202 SHEET 1 AA4 2 GLN B 228 ARG B 232 0 SHEET 2 AA4 2 ILE B 235 TYR B 240 -1 O ARG B 238 N GLY B 230 CRYST1 95.187 117.980 36.480 90.00 90.00 90.00 P 21 21 2 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.010506 0.000000 0.000000 0.00000 SCALE2 0.000000 0.008476 0.000000 0.00000 SCALE3 0.000000 0.000000 0.027412 0.00000